- World rank, all time
- #22,207 of 42,892
- Rank in Netherlands
- #267 of 464
- Research works
- 146 ▲ 38% vs 2013–17
- Citations
- 4.6k 31.6 per fractional work
- Top-10% rate
- 21.8% record average 16.5%
- Open access
- 65% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.2×. Every wedge is a field page.
- Medicine 4.2×
- Neuroscience 3.4×
- Immunology and Microbiology 1.7×
- Nursing 1.3×
- Biochemistry, Genetics and Molecular Biology 1.1×
- Psychology 0.9×
- Chemistry 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.2×
- Business, Management and Accounting 0.2×
- Materials Science 0.1×
- Computer Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Health Professions 0.1×
- Engineering 0.0×
- Environmental Science 0.0×
Who are the top researchers at Synapse (Netherlands)?
Ranked on the composite score, Bas de Laat, Dana Huskens and Mark Roest lead among researchers whose main affiliation is Synapse (Netherlands).
- 1 Bas de Laat Netherlands · #168,350 worldwide 166 citations · 39 works
- 2 Dana Huskens Netherlands · #381,860 worldwide 119 citations · 31 works
- 3 Mark Roest Netherlands · #1,173,554 worldwide 31 citations · 24 works
Which keywords describe research at Synapse (Netherlands)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Hemostasis, Inflammation, Antithrombotic Therapy, Thrombosis, Protease-Activated Receptors, Thrombin, Platelets and Diagnosis.
- Hemorrhage
- Metastasis
- Clopidogrel
- Vaccination
- Heparin-Induced Thrombocytopenia
- Extracellular Matrix
- Coagulopathy
- Catheter Ablation
- Anticoagulant Therapy
- Guidelines
- Cancer
- Venous Thromboembolism
- Clinical Practice Guidelines
- Transglutaminases
- Risk Factors
- von Willebrand Disease
- Diagnosis
- Thrombin
- Thrombosis
- Inflammation
- Hemostasis
- Antithrombotic Therapy
- Protease-Activated Receptors
- Platelets
- Immune Thrombocytopenic Purpura
- Prophylaxis
- Fibrinogen
- Treatment
- Pulmonary Embolism
- Immune Response
- Angiogenesis
- Stroke Prevention
- Atrial Fibrillation
- Risk Stratification
- Cardiovascular Events
- Gene Therapy
- Percutaneous Coronary Intervention
- Aspirin
- Efficacy
- Anemia
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Hemostasis15▲ 326×3 topics
- Inflammation15▲ 15×20 topics
- Antithrombotic Therapy10▲ 255×2 topics
- Thrombosis8▲ 57×6 topics
- Protease-Activated Receptors7▲ 765×1 topic
- Thrombin7▲ 765×1 topic
- Platelets5▲ 160×2 topics
- Diagnosis5▲ 10×5 topics
- Immune Thrombocytopenic Purpura5▲ 370×1 topic
- von Willebrand Disease5▲ 370×1 topic
- Prophylaxis4▲ 69×2 topics
- Risk Factors4▲ 7.4×5 topics
- Fibrinogen4▲ 450×1 topic
- Transglutaminases4▲ 450×1 topic
- Treatment4▲ 5.9×6 topics
- Clinical Practice Guidelines3▲ 12×2 topics
- Pulmonary Embolism3▲ 99×1 topic
- Venous Thromboembolism3▲ 99×1 topic
- Immune Response2▲ 8.7×6 topics
- Cancer2▲ 3.3×9 topics
- Angiogenesis2▲ 13×6 topics
- Guidelines2▲ 8.3×2 topics
- Stroke Prevention2▲ 32×2 topics
- Anticoagulant Therapy2▲ 30×2 topics
- Atrial Fibrillation2▲ 37×1 topic
- Catheter Ablation2▲ 31×2 topics
- Risk Stratification2▲ 51×1 topic
- Coagulopathy2▲ 44×2 topics
- Cardiovascular Events2▲ 26×3 topics
- Extracellular Matrix2▲ 18×2 topics
- Gene Therapy2▲ 16×2 topics
- Heparin-Induced Thrombocytopenia2▲ 201×1 topic
- Percutaneous Coronary Intervention2▲ 23×2 topics
- Vaccination2▲ 41×1 topic
- Aspirin1▲ 136×1 topic
- Clopidogrel1▲ 136×1 topic
- Efficacy1▲ 38×2 topics
- Metastasis1▲ 8.3×5 topics
- Anemia1▲ 29×4 topics
- Hemorrhage1▲ 41×2 topics
Which research topics does Synapse (Netherlands) publish most on?
By volume in 2022–2025: Blood Coagulation and Thrombosis Mechanisms, Platelet Disorders and Treatments, Blood properties and coagulation and Venous Thromboembolism Diagnosis and Management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Blood Coagulation and Thrombosis Mechanisms Hematology 7 works
- 2 Platelet Disorders and Treatments Hematology 5 works
- 3 Blood properties and coagulation Pulmonary and Respiratory Medicine 4 works
- 4 Venous Thromboembolism Diagnosis and Management Internal Medicine 3 works
- 5 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 2 works
- 6 Heparin-Induced Thrombocytopenia and Thrombosis Surgery 2 works
- 7 Antiplatelet Therapy and Cardiovascular Diseases Cardiology and Cardiovascular Medicine 1 works
- 8 Hemophilia Treatment and Research Hematology 1 works
- 9 Trauma, Hemostasis, Coagulopathy, Resuscitation Critical Care and Intensive Care Medicine 1 works
- 10 Cell Adhesion Molecules Research Immunology and Allergy 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Synapse (Netherlands)'s research output changed?
Output in 2018–2022 was 38% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Maastricht
- Maastricht University
- Maastricht University Medical Centre
- Transnational University Limburg
- Maastricht School of Management
- United Nations University – Maastricht Economic and Social Research Institute on Innovation and Technology
- Maastro Clinic
- European Graduate School of Neuroscience
- Social Historic Centre for Limburg
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.